The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation
Instituto Português de Oncologia Francisco Gentil
Country
Portugal
1. Current Status, Position
- Medical Director and Member of the Board of the Instituto Português de Oncologia Francisco Gentil – Lisboa, Portugal (From February 2012).
- Alternate member of the Scientific Advice Working Party of the European Medicines Agency (EMA) (From 2008).
- Member of the Medicines Evaluation Board of the INFARMED (National Institute of Pharmacy and Medicines – Portuguese Drugs Agency) (From 1996).
- Member of the Protocol Review Committee of the EORTC (From 2001).
2. Education
- 1978: M.D. University of Lisboa
- 1983 – 1986: Fellowship Clinical Hematology, Hospitais Civis de Lisboa, Portugal.
- 1986 – 1988: Fellowship Medical Oncology, Institut Gustave Roussy, Villejuif, France.
- 1989 – 1991: Clinical Hematologist, Hospitais Civis de Lisboa, Portugal.
- 1991 – 2001 and 2006 – 2012: Medical Oncologist, Instituto Português de Oncologia Francisco Gentil – Lisboa, Portugal.
- 2001 – 2005: Medical Director of the Instituto Português de Oncologia Francisco Gentil – Lisboa, Portugal
3. Research Area
João's has focuses his work research on:
- Clinical care, and development and assessment of chemotherapy and combined treatments in Head and Neck, Gastric, Colorectal, and Breast cancer,
- Methodology of Clinical Research,
- Organization of Health Services.